Literature DB >> 25259408

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Jiemiao Hu1, Jun Yan1, Ganesh Rao2, Khatri Latha2, Willem W Overwijk3, Amy B Heimberger2, Shulin Li1.   

Abstract

Fibrinogen-like protein 2 (Fgl2), a member of the fibrinogen family, can be expressed as a membrane-associated protein with coagulation activity or in a secreted form possessing unique immune suppressive functions. The biological importance of Fgl2 is evident within viral-induced fibrin depositing inflammatory diseases and malignancies and provides a compelling rationale for Fgl2 expression to not only be considered as a disease biomarker but also as a therapeutic target. This article will provide a comprehensive review of the currently known biological properties of Fgl2 and clarifies future scientific directives.

Entities:  

Keywords:  DC maturation; Tregs; fibrin deposit; glioblastoma; immune suppression; inflammatory diseases; liver injury; membrane-bound procoagulant; secreted immune checkpoint regulator

Mesh:

Substances:

Year:  2014        PMID: 25259408      PMCID: PMC5257246          DOI: 10.3109/08830185.2014.956360

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  86 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.

Authors:  M J Nadler; B Chen; J S Anderson; H H Wortis; B G Neel
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

Review 3.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

5.  Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection.

Authors:  Qingsheng Li; Anthony J Smith; Timothy W Schacker; John V Carlis; Lijie Duan; Cavan S Reilly; Ashley T Haase
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

6.  The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression.

Authors:  Hao Liu; Itay Shalev; Justin Manuel; Wei He; Elisa Leung; Jennifer Crookshank; Ming F Liu; Jun Diao; Mark Cattral; David A Clark; David E Isenman; Reginald M Gorczynski; David R Grant; Li Zhang; Melville J Phillips; Myron I Cybulsky; Gary A Levy
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

7.  Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2.

Authors:  Hao Liu; Peter S Yang; Tina Zhu; Justin Manuel; Jianhua Zhang; Wei He; Itay Shalev; Li Zhang; Myron I Cybulsky; David R Grant; M James Phillips; Gary A Levy
Journal:  Int J Biochem Cell Biol       Date:  2012-11-02       Impact factor: 5.085

8.  Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice.

Authors:  Junwu Mu; Dawei Qu; Agata Bartczak; M James Phillips; Justin Manuel; Wei He; Cheryl Koscik; Michael Mendicino; Li Zhang; David A Clark; David R Grant; Peter H Backx; Gary A Levy; S Lee Adamson
Journal:  Physiol Genomics       Date:  2007-06-05       Impact factor: 3.107

9.  Identification of genes associated with the progression of adult T cell leukemia (ATL).

Authors:  T Kohno; R Moriuchi; S Katamine; Y Yamada; M Tomonaga; T Matsuyama
Journal:  Jpn J Cancer Res       Date:  2000-11

10.  Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3.

Authors:  P J MacPhee; V J Dindzans; L S Fung; G A Levy
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

View more
  25 in total

1.  FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Authors:  Jun Yan; Ling-Yuan Kong; Jiemiao Hu; Konrad Gabrusiewicz; Denada Dibra; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  J Natl Cancer Inst       Date:  2015-05-13       Impact factor: 13.506

Review 2.  The intertwined fates of inflammation and coagulation in glioma.

Authors:  Angela Cho; Kelly J McKelvey; Adrian Lee; Amanda L Hudson
Journal:  Mamm Genome       Date:  2018-07-30       Impact factor: 2.957

Review 3.  Activation and regulation of alloreactive T cell immunity in solid organ transplantation.

Authors:  Charlotte Duneton; Pamela D Winterberg; Mandy L Ford
Journal:  Nat Rev Nephrol       Date:  2022-07-27       Impact factor: 42.439

4.  Mutant IDH1 and thrombosis in gliomas.

Authors:  Dusten Unruh; Steven R Schwarze; Laith Khoury; Cheddhi Thomas; Meijing Wu; Li Chen; Rui Chen; Yinxing Liu; Margaret A Schwartz; Christina Amidei; Priya Kumthekar; Carolina G Benjamin; Kristine Song; Caleb Dawson; Joanne M Rispoli; Girish Fatterpekar; John G Golfinos; Douglas Kondziolka; Matthias Karajannis; Donato Pacione; David Zagzag; Thomas McIntyre; Matija Snuderl; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2016-09-23       Impact factor: 17.088

5.  Memory T cell-mediated rejection is mitigated by FcγRIIB expression on CD8+ T cells.

Authors:  Anna B Morris; David F Pinelli; Danya Liu; Maylene Wagener; Mandy L Ford
Journal:  Am J Transplant       Date:  2020-03-24       Impact factor: 8.086

6.  Fibrinogen-like protein-2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death-1 and inflammatory cytokines.

Authors:  Zhenzhong Zheng; Yinghui Yu; Ratnakar Potla; Yujing Wu; Hao Wu
Journal:  Immunology       Date:  2017-10-16       Impact factor: 7.397

7.  The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.

Authors:  Khatri Latha; Jun Yan; Yuhui Yang; Loyola V Gressot; Ling-Yuan Kong; Ganiraju Manyam; Ravesanker Ezhilarasan; Qianghu Wang; Erik P Sulman; R Eric Davis; Suyun Huang; Gregory N Fuller; Arvind Rao; Amy B Heimberger; Shulin Li; Ganesh Rao
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

8.  Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation.

Authors:  Adelle P McFarland; Adam Yalin; Shuang-Yin Wang; Victor S Cortez; Tomer Landsberger; Raki Sudan; Vincent Peng; Hannah L Miller; Biancamaria Ricci; Eyal David; Roberta Faccio; Ido Amit; Marco Colonna
Journal:  Immunity       Date:  2021-05-03       Impact factor: 43.474

9.  Integrated analysis of dosage effect lncRNAs in lung adenocarcinoma based on comprehensive network.

Authors:  Yunzhen Wei; Zichuang Yan; Cheng Wu; Qiang Zhang; Yinling Zhu; Kun Li; Yan Xu
Journal:  Oncotarget       Date:  2017-08-03

10.  Intrauterine inflammation induced white matter injury protection by fibrinogen-like protein 2 deficiency in perinatal mice.

Authors:  Di Zhan; Cai Zhang; Wenjun Long; Lan Wei; Shengjuan Jin; Caiqi Du; Zhuxi Li; Shusen Guo; Lianjing Huang; Qin Ning; Xiaoping Luo
Journal:  Pediatr Res       Date:  2020-10-19       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.